Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases

Lara Testai, Alma Martelli, Lorenzo Flori, Arrigo F G Cicero, Alessandro Colletti, Lara Testai, Alma Martelli, Lorenzo Flori, Arrigo F G Cicero, Alessandro Colletti

Abstract

Coenzyme Q10 (CoQ10) is an essential cofactor in oxidative phosphorylation (OXPHOS), present in mitochondria and cell membranes in reduced and oxidized forms. Acting as an energy transfer molecule, it occurs in particularly high levels in the liver, heart, and kidneys. CoQ10 is also an anti-inflammatory and antioxidant agent able to prevent the damage induced by free radicals and the activation of inflammatory signaling pathways. In this context, several studies have shown the possible inverse correlation between the blood levels of CoQ10 and some disease conditions. Interestingly, beyond cardiovascular diseases, CoQ10 is involved also in neuronal and muscular degenerative diseases, in migraine and in cancer; therefore, the supplementation with CoQ10 could represent a viable option to prevent these and in some cases might be used as an adjuvant to conventional treatments. This review is aimed to summarize the clinical applications regarding the use of CoQ10 in migraine, neurodegenerative diseases (including Parkinson and Alzheimer diseases), cancer, or degenerative muscle disorders (such as multiple sclerosis and chronic fatigue syndrome), analyzing its effect on patients' health and quality of life.

Keywords: cancer; coenzyme Q10; neuronal and muscular degenerative disorders; prevention; supplementation; ubiquinone.

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1
Figure 1
Chemical structure of CoQ10.
Figure 2
Figure 2
Coenzyme Q10 physiology.

References

    1. Bentinger M., Brismar K., Dallner G. The antioxidant role of coenzyme Q. Mitochondrion. 2007;7:S41–S50. doi: 10.1016/j.mito.2007.02.006.
    1. Saini R. Coenzyme Q10: The essential nutrient. J. Pharm. Bioallied Sci. 2011;3:466–467. doi: 10.4103/0975-7406.84471.
    1. Crane F.L. Biochemical Functions of Coenzyme Q10. J. Am. Coll. Nutr. 2001;20:591–598. doi: 10.1080/07315724.2001.10719063.
    1. Haas R.H. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease. Mitochondrion. 2007;7:S136–S145. doi: 10.1016/j.mito.2007.03.008.
    1. Gutierrez-Mariscal F.M., Yubero-Serrano E.M., Villalba J.M., Lopez-Miranda J. Coenzyme Q10: From bench to clinic in aging diseases, a translational review. Crit. Rev. Food Sci. Nutr. 2019;59:2240–2257. doi: 10.1080/10408398.2018.1442316.
    1. Schmelzer C., Lindner I., Rimbach G., Niklowitz P., Menke T., Döring F. Functions of coenzyme Q10in inflammation and gene expression. BioFactors. 2008;32:179–183. doi: 10.1002/biof.5520320121.
    1. Yubero-Serrano E.M., Gonzalez-Guardia L., Rangel-Zuñiga O., Delgado-Lista J., Gutierrez-Mariscal F.M., Perez-Martinez P., Delgado-Casado N., Cruz-Teno C., Tinahones F.J., Villalba J.M., et al. Mediterranean Diet Supplemented With Coenzyme Q10 Modifies the Expression of Proinflammatory and Endoplasmic Reticulum Stress-Related Genes in Elderly Men and Women. J. Gerontol. Ser. A Boil. Sci. Med. Sci. 2011;67:3–10. doi: 10.1093/gerona/glr167.
    1. Shukla S., Dubey K.K. CoQ10 a super-vitamin: Review on application and biosynthesis. 3 Biotech. 2018;8:1–11. doi: 10.1007/s13205-018-1271-6.
    1. Szkopińska A. Ubiquinone. Biosynthesis of quinone ring and its isoprenoid side chain. Intracellular localization. Acta Biochim. Pol. 2000;47:469–480. doi: 10.18388/abp.2000_4027.
    1. Turunen M., Olsson J., Dallner G. Metabolism and function of coenzyme Q. Biochim. Biophys. Acta (BBA) Biomembr. 2004;1660:171–199. doi: 10.1016/j.bbamem.2003.11.012.
    1. Weber C., Bysted A., Hłlmer G. The coenzyme Q10 content of the average Danish diet. Int. J. Vitam. Nutr. Res. 1997;67:123–129.
    1. Zhang Y., Aberg F., Appelkvist E.L., Dallner G., Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J. Nutr. 1995;125:446–453.
    1. Garrido-Maraver J., Cordero M.D., Oropesa-Ávila M., Vega A.F., De La Mata M., Pavón A.D., De Miguel M., Calero C.P., Paz M.V., Cotán D., et al. Coenzyme q10 therapy. Mol. Syndr. 2014;5:187–197. doi: 10.1159/000360101.
    1. Åberg F., Appelkvist E.-L., Dallner G., Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch. Biochem. Biophys. 1992;295:230–234. doi: 10.1016/0003-9861(92)90511-T.
    1. Miles M.V., Horn P.S., Morrison J.A., Tang P.H., Degrauw T., Pesce A.J. Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin. Chim. Acta. 2003;332:123–132. doi: 10.1016/S0009-8981(03)00137-2.
    1. Weis M., Mortensen S., Rassing M., Møller-Sonnergaard J., Poulsen G., Rasmussen S. Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteers. Mol. Asp. Med. 1994;15:s273–s280. doi: 10.1016/0098-2997(94)90038-8.
    1. Martelli A., Testai L., Colletti A., Cicero A.F.G. Coenzyme Q10: Clinical Applications in Cardiovascular Diseases. Antioxidants. 2020;9:341. doi: 10.3390/antiox9040341.
    1. Miles M.V., Horn P., Miles L., Tang P., Steele P., Degrauw T. Bioequivalence of coenzyme Q10 from over-the-counter supplements. Nutr. Res. 2002;22:919–929. doi: 10.1016/S0271-5317(02)00402-5.
    1. Kumar S., Rao R., Kumar A., Mahant S., Nanda S. Novel Carriers for Coenzyme Q10 Delivery. Curr. Drug Deliv. 2016;13:1184–1204. doi: 10.2174/1567201813666160104130631.
    1. Hershey A.D., Powers S.W., Vockell A.-L.B., LeCates S.L., Ellinor P.L., Segers A., Burdine D., Manning P., Kabbouche M.A. Coenzyme Q10 Deficiency and Response to Supplementation in Pediatric and Adolescent Migraine. Headache J. Head Face Pain. 2007;47:73–80. doi: 10.1111/j.1526-4610.2007.00652.x.
    1. Dahri M., Tarighat-Esfanjani A., Asghari-Jafarabadi M., Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers. Nutr. Neurosci. 2018;22:607–615. doi: 10.1080/1028415X.2017.1421039.
    1. Parohan M., Sarraf P., Javanbakht M.H., Ranji-Burachaloo S., Djalali M. Effect of coenzyme Q10 supplementation on clinical features of migraine: A systematic review and dose-response meta-analysis of randomized controlled trials. Nutr. Neurosci. 2019;23:868–875. doi: 10.1080/1028415X.2019.1572940.
    1. Zeng Z., Li Y., Lu S., Huang W., Di W. Efficacy of CoQ10 as supplementation for migraine: A meta-analysis. Acta Neurol. Scand. 2018;139:284–293. doi: 10.1111/ane.13051.
    1. Gaul C., Diener H.C., Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: A randomized, placebo-controlled, double-blind, multicenter trial. J. Headache Pain. 2015;16:1–8. doi: 10.1186/s10194-015-0516-6.
    1. Parohan M., Sarraf P., Javanbakht M.H., Foroushani A.R., Ranji-Burachaloo S., Djalali M. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial. Nutr. Neurosci. 2021;24:317–326. doi: 10.1080/1028415X.2019.1627770.
    1. Mizuno K., Tanaka M., Yamaguti K., Kajimoto O., Kuratsune H., Watanabe Y. Mental fatigue caused by prolonged cognitive load associated with sympathetic hyperactivity. Behav. Brain Funct. 2011;7:1–17. doi: 10.1186/1744-9081-7-17.
    1. Mizuno K., Tanaka M., Nozaki S., Mizuma H., Ataka S., Tahara T., Sugino T., Shirai T., Kajimoto Y., Kuratsune H., et al. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition. 2008;24:293–299. doi: 10.1016/j.nut.2007.12.007.
    1. Mehrabani S., Askari G., Miraghajani M., Tavakoly R., Arab A. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies. Complement. Ther. Med. 2019;43:181–187. doi: 10.1016/j.ctim.2019.01.022.
    1. Yancey J.R., Thomas S.M. Chronic fatigue syndrome: Diagnosis and treatment. Am. Fam. Physician. 2012;86:741–746.
    1. Cooke M., Iosia M., Buford T., Shelmadine B., Hudson G., Kerksick C., Rasmussen C., Greenwood M., Leutholtz B., Willoughby D., et al. Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J. Int. Soc. Sports Nutr. 2008;5:1–14. doi: 10.1186/1550-2783-5-8.
    1. Bjørklund G., Dadar M., Pen J.J., Chirumbolo S., Aaseth J. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach. Biomed. Pharmacother. 2019;109:1000–1007. doi: 10.1016/j.biopha.2018.10.076.
    1. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol. Lett. 2009;30:470–476.
    1. Booth N.E., Myhill S., McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Int. J. Clin. Exp. Med. 2012;5:208–220.
    1. Castro-Marrero J., Cordero M.D., Segundo M.J., Sáez-Francàs N., Calvo N., Román-Malo L., Aliste L., De Sevilla T.F., Alegre J. Does Oral Coenzyme Q10 Plus NADH Supplementation Improve Fatigue and Biochemical Parameters in Chronic Fatigue Syndrome? Antioxid. Redox Signal. 2015;22:679–685. doi: 10.1089/ars.2014.6181.
    1. Morris G., Maes M. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome. Metab. Brain Dis. 2012;28:523–540. doi: 10.1007/s11011-012-9324-8.
    1. Nicolson G.L. Mitochondrial dysfunction and chronic disease: Treatment with natural supplements. Integr. Med. Clin. J. 2014;13:35.
    1. Alegre J., Rosés J., Javierre C., Ruiz-Baqués A., Segundo M., De Sevilla T.F. Nicotinamida adenina dinucleótido (NADH) en pacientes con síndrome de fatiga crónica. Clín. Esp. 2010;210:284–288. doi: 10.1016/j.rce.2009.09.015.
    1. Castro-Marrero J., Sáez-Francàs N., Segundo M.J., Calvo N., Faro M., Aliste L., de Sevilla T.F., Alegre J. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome: A randomized, controlled, double-blind trial. Clin. Nutr. 2016;35:826–834. doi: 10.1016/j.clnu.2015.07.010.
    1. Fukuda S., Nojima J., Kajimoto O., Yamaguti K., Nakatomi Y., Kuratsune H., Watanabe Y. Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome. BioFactors. 2016;42:431–440. doi: 10.1002/biof.1293.
    1. Di Pierro F., Rossi A., Consensi A., Giacomelli C., Bazzichi L. Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study. Clin. Exp. Rheumatol. 2016;35:20–27.
    1. Cordero M.D., Santos-García R., Bermejo-Jover D., Sánchez-Domínguez B., Jaramillo-Santos M.R., Bullon P. Coenzyme Q10 in salivary cells correlate with blood cells in Fibromyalgia: Improvement in clinical and biochemical parameter after oral treatment. Clin. Biochem. 2012;45:509–511. doi: 10.1016/j.clinbiochem.2012.02.001.
    1. Cordero M.D., Alcocer-Gómez E., De Miguel M., Culic O., Carrión A.M., Alvarez-Suarez J.M., Bullón P., Battino M., Fernández-Rodríguez A., Sánchez-Alcazar J.A. Can Coenzyme Q10 Improve Clinical and Molecular Parameters in Fibromyalgia? Antioxid. Redox Signal. 2013;19:1356–1361. doi: 10.1089/ars.2013.5260.
    1. Hardie D.G., Ross F.A., Hawley S.A. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012;13:251–262. doi: 10.1038/nrm3311.
    1. Tsai K.L., Chen L.H., Chiou S.H., Chiou G.Y., Chen Y.C., Chou H.Y., Chen L.K., Chen H.Y., Chiu T.H., Tsai C.S., et al. Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway. Mol. Nutr. Food Res. 2011;55:S227–S240. doi: 10.1002/mnfr.201100147.
    1. Langsjoen P.H., Langsjoen J.O., Langsjoen A.M., Lucas L.A. Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. BioFactors. 2005;25:147–152. doi: 10.1002/biof.5520250116.
    1. Cordero M.D., Cano-García F.J., Alcocer-Gómez E., De Miguel M., Sánchez-Alcázar J.A. Oxidative Stress Correlates with Headache Symptoms in Fibromyalgia: Coenzyme Q10 Effect on Clinical Improvement. PLoS ONE. 2012;7:e35677. doi: 10.1371/journal.pone.0035677.
    1. Miyamae T., Seki M., Naga T., Uchino S., Asazuma H., Yoshida T., Iizuka Y., Kikuchi M., Imagawa T., Natsumeda Y., et al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: Amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep. 2013;18:12–19. doi: 10.1179/1351000212Y.0000000036.
    1. Corsini A. Statin-Related Muscle Complaints: An Underestimated Risk. Cardiovasc. Drugs Ther. 2005;19:379–381. doi: 10.1007/s10557-005-6352-1.
    1. Deichmann R., Lavie C., Andrews S. Coenzyme Q10 and Statin-Induced Mitochondrial Dysfunction. Ochsner J. 2010;10:16–21.
    1. Fedacko J., Pella D., Fedackova P., Hänninen O., Tuomainen P., Jarcuska P., Lopuchovsky T., Jedlickova L., Merkovska L., Littarru G.P. Coenzyme Q10and selenium in statin-associated myopathy treatment. Can. J. Physiol. Pharmacol. 2013;91:165–170. doi: 10.1139/cjpp-2012-0118.
    1. Gharahdaghi N., Shabkhiz F., Azarboo E., Keyhanian A. The effects of daily coenzyme Q10 supplementation on VO2max, vVO2max and Intermittent Exercise performance in soccer players. Life Sci. J. 2013;10:22–28.
    1. Lee Y.J., Cho W.J., Kim J.K., Lee D.C. Effects of Coenzyme Q10 on Arterial Stiffness, Metabolic Parameters, and Fatigue in Obese Subjects: A Double-Blind Randomized Controlled Study. J. Med. Food. 2011;14:386–390. doi: 10.1089/jmf.2010.1202.
    1. Gökbel H., Gül I., Belviranl M., Okudan N. The Effects Of Coenzyme Q10 Supplementation on Performance During Repeated Bouts of Supramaximal Exercise in Sedentary Men. J. Strength Cond. Res. 2010;24:97–102. doi: 10.1519/JSC.0b013e3181a61a50.
    1. Ylikoski T., Piirainen J., Hanninen O., Penttinen J. The effect of coenzyme Q10 on the exercise performance of cross-country skiers. Mol. Asp. Med. 1997;18:283–290. doi: 10.1016/S0098-2997(97)00038-1.
    1. Macdonald J., Galley H., Webster N. Oxidative stress and gene expression in sepsis. Br. J. Anaesth. 2003;90:221–232. doi: 10.1093/bja/aeg034.
    1. Kreher J.B., Schwartz J.B. Overtraining Syndrome. Sports Health. 2012;4:128–138. doi: 10.1177/1941738111434406.
    1. Bonetti A., Solito F., Carmosino G., Bargossi A.M., Fiorella P.L. Effect of ubidecarenone oral treatment on aerobic power in middle-aged trained subjects. J. Sports Med. Phys. Fit. 2000;40:51.
    1. Malm C., Svensson M., Ekblom B., Sjödin B. Effects of ubiquinone-10 supplementation and high intensity training on physical performance in humans. Acta Physiol. Scand. 1997;161:379–384. doi: 10.1046/j.1365-201X.1997.00198.x.
    1. Stear S.J., Castell L.M., Burke L.M., Jeacocke N., Ekblom B., Shing C., Calder P.C., Lewis N. A-Z of nutritional supplements: Dietary supplements, sports nutrition foods and ergogenic aids for health and performance—part 10. Br. J. Sports Med. 2010;44:688–690. doi: 10.1136/bjsm.2010.075218.
    1. Liao P., Zhang Y., Liao Y., Zheng N.-J., Zhang X. Effects of coenzyme Q10 supplementation on liver mitochondrial function and aerobic capacity in adolescent athletes. J. Appl. Physiol. 2007;23:491–494.
    1. Weston S.B., Zhou S., Weatherby R.P., Robson S.J. Does Exogenous Coenzyme Q10 Affect Aerobic Capacity in Endurance Athletes? Int. J. Sport Nutr. 1997;7:197–206. doi: 10.1123/ijsn.7.3.197.
    1. Imai H., Hayashi T., Negawa T., Nakamura K., Tomida M., Koda K., Tajima T., Koda Y., Suda K., Era S. Strenuous Exercise-Induced Change in Redox State of Human Serum Albumin during Intensive Kendo Training. Jpn. J. Physiol. 2002;52:135–140. doi: 10.2170/jjphysiol.52.135.
    1. Kon M., Tanabe K., Akimoto T., Kimura F., Tanimura Y., Shimizu K., Okamoto T., Kono I. Reducing exercise-induced muscular injury in kendo athletes with supplementation of coenzyme Q10. Br. J. Nutr. 2008;100:903–909. doi: 10.1017/S0007114508926544.
    1. Shimizu K., Kon M., Tanimura Y., Hanaoka Y., Kimura F., Akama T., Kono I. Coenzyme Q10 supplementation downregulates the increase of monocytes expressing toll-like receptor 4 in response to 6-day intensive training in kendo athletes. Appl. Physiol. Nutr. Metab. 2015;40:575–581. doi: 10.1139/apnm-2014-0556.
    1. Armanfar M., Jafari A., Dehghan G.R. Effect of coenzyme Q10 Supplementation on Exercise-Induced Response of Oxidative Stress and Muscle Damage Indicators in Male Runners. Med. J. Islam. Repub. Iran. 2015;17:202. doi: 10.17795/zjrms1023.
    1. Emami A. The Impact of Pre-Cooling and CoQ10Supplementation on Mediators of Inflammatory Cytokines in Elite Swimmers. Nutr. Cancer. 2020;72:41–51. doi: 10.1080/01635581.2019.1614200.
    1. Berman M., Erman A., Ben-Gal T., Dvir D., Georghiou G.P., Stamler A., Vered Y., Vidne B.A., Aravot D. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: A randomized, placebo-controlled study. Clin. Cardiol. 2004;27:295–299. doi: 10.1002/clc.4960270512.
    1. Peel M.M., Cooke M., Lewis-Peel H.J., Lea R.A., Moyle W. A randomized controlled trial of coenzyme Q10 for fatigue in the late-onset sequelae of poliomyelitis. Complement. Ther. Med. 2015;23:789–793. doi: 10.1016/j.ctim.2015.09.002.
    1. Lesser G.J., Case D., Stark N., Williford S., Giguere J., Garino L.A., Naughton M.J., Vitolins M.Z., Lively M.O., Shaw E.G. A Randomized, Double-Blind, Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Treatment-Related Fatigue in Newly Diagnosed Patients with Breast Cancer. J. Support. Oncol. 2012;11:31–42. doi: 10.1016/j.suponc.2012.03.003.
    1. Liu J., Wang L.N., Zhan S.Y., Xia Y. Coenzyme Q10 for Parkinson’s disease. Cochrane Database Syst. Rev. 2012:CD008150. doi: 10.1002/14651858.CD008150.pub3.
    1. Shults C.W., Haas R.H., Passov D., Beal M.F. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann. Neurol. 1997;42:261–264. doi: 10.1002/ana.410420221.
    1. Matsubara T. Serum coenzyme Q-10 level in parkinson syndrome. In: Folkers K., Littarru G.P., Yamagami T., editors. Biomedical and Clinical Aspects of Coenzyme Q. Elsevier Science Publishers; New York, NY, USA: 1991. pp. 159–166.
    1. Müller T., Büttner T., Gholipour A.-F., Kuhn W. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson’s disease. Neurosci. Lett. 2003;341:201–204. doi: 10.1016/S0304-3940(03)00185-X.
    1. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., et al. Effects of Coenzyme Q10 in Early Parkinson Disease. Arch. Neurol. 2002;59:1541–1550. doi: 10.1001/archneur.59.10.1541.
    1. Horstink M.W.I.M., Van Engelen B.G. The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic. Arch. Neurol. 2003;60:1170–1172. doi: 10.1001/archneur.60.8.1170-b.
    1. Shults C.W., Beal M.F., Song D., Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson’s disease. Exp. Neurol. 2004;188:491–494. doi: 10.1016/j.expneurol.2004.05.003.
    1. Storch A., Jost W.H., Vieregge P., Spiegel J., Greulich W., Durner J., Müller T., Kupsch A., Henningsen H., Oertel W.H., et al. Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease. Arch. Neurol. 2007;64:938–944. doi: 10.1001/archneur.64.7.nct60005.
    1. Beal M.F., Oakes D., Shoulson I., Henchcliffe C., Galpern W.R., Haas R., Juncos J.L., Nutt J.G., Voss T.S., Ravina B., et al. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease. JAMA Neurol. 2014;71:543–552. doi: 10.1001/jamaneurol.2014.131.
    1. Cleren C., Yang L., Lorenzo B., Calingasan N.Y., Schomer A., Sireci A., Wille E.J., Beal M.F. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J. Neurochem. 2007;104:1613–1621. doi: 10.1111/j.1471-4159.2007.05097.x.
    1. Yoritaka A., Kawajiri S., Yamamoto Y., Nakahara T., Ando M., Hashimoto K., Nagase M., Saito Y., Hattori N. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson’s disease. Park. Relat. Disord. 2015;21:911–916. doi: 10.1016/j.parkreldis.2015.05.022.
    1. The Huntington Study Group A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology. 2001;57:397–404. doi: 10.1212/wnl.57.3.397.
    1. McGarry A., McDermott M., Kieburtz K., De Blieck E.A., Beal F., Marder K., Ross C., Shoulson I., Gilbert P., Mallonee W.M., et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017;88:152–159. doi: 10.1212/WNL.0000000000003478.
    1. Galasko D.R., Peskind E., Clark C.M., Quinn J.F., Ringman J.M., Jicha G.A., Cotman C., Cottrell B., Montine T.J., Thomas R.G., et al. Antioxidants for Alzheimer Disease. Arch. Neurol. 2012;69:836–841. doi: 10.1001/archneurol.2012.85.
    1. Janardhan V., Bakshi R. Quality of life in patients with multiple sclerosis. J. Neurol. Sci. 2002;205:51–58. doi: 10.1016/S0022-510X(02)00312-X.
    1. Kos D., Kerckhofs E., Nagels G., D’Hooghe M.B., Ilsbroukx S. Origin of Fatigue in Multiple Sclerosis: Review of the Literature. Neurorehabilit. Neural Repair. 2007;22:91–100. doi: 10.1177/1545968306298934.
    1. Vercoulen J.H.M.M., Hommes O.R., Swanink C.M.A., Jongen P.J.H., Fennis J.F.M., Galama J.M.D., Van Der Meer J.W.M., Bleijenberg G. The Measurement of Fatigue in Patients with Multiple Sclerosis. Arch. Neurol. 1996;53:642–649. doi: 10.1001/archneur.1996.00550070080014.
    1. Gold S.M., Irwin M.R. Depression and Immunity: Inflammation and Depressive Symptoms in Multiple Sclerosis. Neurol. Clin. 2006;24:507–519. doi: 10.1016/j.ncl.2006.03.007.
    1. Bilici M., Efe H., Köroğlu M., Uydu H.A., Bekaroğlu M., Değer O. Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. J. Affect. Disord. 2001;64:43–51. doi: 10.1016/S0165-0327(00)00199-3.
    1. Sanoobar M., Dehghan P., Khalili M., Azimi A., Seifar F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial. Nutr. Neurosci. 2015;19:138–143. doi: 10.1179/1476830515Y.0000000002.
    1. Fakhrabadi M.A., Ghotrom A.Z., Mozaffari-Khosravi H., Nodoushan H.H., Nadjarzadeh A., Information R. Effect of Coenzyme Q10 on Oxidative Stress, Glycemic Control and Inflammation in Diabetic Neuropathy: A Double Blind Randomized Clinical Trial. Int. J. Vitam. Nutr. Res. 2014;84:252–260. doi: 10.1024/0300-9831/a000211.
    1. Parisi V., Centofanti M., Gandolfi S., Marangoni D., Rossetti L., Tanga L., Tardini M., Traina S., Ungaro N., Vetrugno M., et al. Effects of Coenzyme Q10 in Conjunction With Vitamin E on Retinal-evoked and Cortical-evoked Responses in Patients With Open-angle Glaucoma. J. Glaucoma. 2014;23:391–404. doi: 10.1097/IJG.0b013e318279b836.
    1. Ozates S., Elgin K.U., Yilmaz N.S., Demirel O.O., Sen E., Yilmazbas P. Evaluation of oxidative stress in pseudo-exfoliative glaucoma patients treated with and without topical coenzyme Q10 and vitamin E. Eur. J. Ophthalmol. 2019;29:196–201. doi: 10.1177/1120672118779486.
    1. Premkumar V.G., Yuvaraj S., Vijayasarathy K., Gangadaran S.G.D., Sachdanandam P. Effect of Coenzyme Q10, Riboflavin and Niacin on Serum CEA and CA 15-3 Levels in Breast Cancer Patients Undergoing Tamoxifen Therapy. Biol. Pharm. Bull. 2007;30:367–370. doi: 10.1248/bpb.30.367.
    1. Premkumar V.G., Yuvaraj S., Shanthi P., Sachdanandam P. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. Br. J. Nutr. 2008;100:1179–1182. doi: 10.1017/S0007114508968276.
    1. Premkumar V.G., Yuvaraj S., Sathish S., Shanthi P., Sachdanandam P. Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy. Vasc. Pharmacol. 2008;48:191–201. doi: 10.1016/j.vph.2008.02.003.
    1. Liu H.T., Huang Y.C., Cheng S.B., Huang Y.T., Lin P.T. Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: A randomized, placebo-controlled trial. Nutr. J. 2015;15:1–9. doi: 10.1186/s12937-016-0205-6.
    1. Iwase S., Kawaguchi T., Yotsumoto D., Doi T., Miyara K., Odagiri H., Kitamura K., Ariyoshi K., Miyaji T., Ishiki H., et al. Efficacy and safety of an amino acid jelly containing coenzyme Q10 and l-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: A multi-institutional, randomized, exploratory trial (JORTC-CAM01) Support. Care Cancer. 2015;24:637–646. doi: 10.1007/s00520-015-2824-4.
    1. Hoenjet K., Dagnelie P., Delaere K., Wijckmans N., Zambon J., Oosterhof G. Effect of a Nutritional Supplement Containing Vitamin E, Selenium, Vitamin C and Coenzyme Q10 on Serum PSA in Patients with Hormonally Untreated Carcinoma of the Prostate: A Randomised Placebo-Controlled Study. Eur. Urol. 2005;47:433–440. doi: 10.1016/j.eururo.2004.11.017.
    1. Rusciani L., Proietti I., Rusciani A., Paradisi A., Sbordoni G., Alfano C., Panunzi S., De Gaetano A., Lippa S. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J. Am. Acad. Dermatol. 2006;54:234–241. doi: 10.1016/j.jaad.2005.08.031.
    1. Rusciani L., Proietti I., Paradisi A., Rusciani A., Guerriero G., Mammone A., De Gaetano A., Lippa S. Recombinant interferon α-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: A 3-year trial with recombinant interferon-α and 5-year follow-up. Melanoma Res. 2007;17:177–183. doi: 10.1097/CMR.0b013e32818867a0.
    1. Sharlip I.D., Jarow J.P., Belker A.M., Lipshultz L.I., Sigman M., Thomas A.J., Schlegel P.N., Howards S.S., Nehra A., Damewood M.D., et al. Best practice policies for male infertility. Fertil. Steril. 2002;77:873–882. doi: 10.1016/S0015-0282(02)03105-9.
    1. Eroglu M., Sahin S., Durukan B., Ozakpinar O.B., Erdinc N., Turkgeldi L., Sofuoglu K., Karateke A. Blood Serum and Seminal Plasma Selenium, Total Antioxidant Capacity and Coenzyme Q10 Levels in Relation to Semen Parameters in Men with Idiopathic Infertility. Biol. Trace Elem. Res. 2014;159:46–51. doi: 10.1007/s12011-014-9978-7.
    1. Balercia G., Buldreghini E., Vignini A., Tiano L., Paggi F., Amoroso S., Ricciardo-Lamonica G., Boscaro M., Lenzi A., Littarru G. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: A placebo-controlled, double-blind randomized trial. Fertil. Steril. 2009;91:1785–1792. doi: 10.1016/j.fertnstert.2008.02.119.
    1. Safarinejad M.R., Safarinejad S., Shafiei N., Safarinejad S. Effects of the Reduced Form of Coenzyme Q 10 (Ubiquinol) on Semen Parameters in Men with Idiopathic Infertility: A Double-Blind, Placebo Controlled, Randomized Study. J. Urol. 2012;188:526–531. doi: 10.1016/j.juro.2012.03.131.
    1. Nadjarzadeh A., Sadeghi M.R., Amirjannati N., Vafa M.R., Motevalian S.A., Gohari M.R., Akhondi M.A., Yavari P., Shidfar F. Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: A randomized double-blind, placebo controlled trial. J. Endocrinol. Investig. 2011;34:e224–e228.
    1. Pasqualotto F.F., Sundaram A., Sharma R.K., Borges E., Pasqualotto E.B., Agarwal A. Semen quality and oxidative stress scores in fertile and infertile patients with varicocele. Fertil. Steril. 2008;89:602–607. doi: 10.1016/j.fertnstert.2007.03.057.
    1. Festa R., Giacchi E., Raimondo S., Tiano L., Zuccarelli P., Silvestrini A., Meucci E., Littarru G.P., Mancini A. Coenzyme Q10supplementation in infertile men with low-grade varicocele: An open, uncontrolled pilot study. Andrologia. 2013;46:805–807. doi: 10.1111/and.12152.
    1. Ibáñez L., Oberfield S.E., Witchel S.F., Auchus R.J., Chang R.J., Codner E., Dabadghao P., Darendeliler F., Elbarbary N.S., Gambineri A., et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm. Res. Paediatr. 2017;88:371–395. doi: 10.1159/000479371.
    1. Agapova S.E., Cameo T., Sopher A.B., Oberfield S.E. Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence. Semin. Reprod. Med. 2014;32:194–201. doi: 10.1055/s-0034-1371091.
    1. Azziz R. Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature. J. Clin. Endocrinol. Metab. 2006;91:781–785. doi: 10.1210/jc.2005-2153.
    1. Banihani S.A. Effect of Coenzyme Q10 Supplementation on Testosterone. Biomolecules. 2018;8:172. doi: 10.3390/biom8040172.
    1. Samimi M., Mehrizi M.Z., Foroozanfard F., Akbari H., Jamilian M., Ahmadi S., Asemi Z. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Clin. Endocrinol. 2017;86:560–566. doi: 10.1111/cen.13288.
    1. Rahmani E., Jamilian M., Samimi M., Mehrizi M.Z., Aghadavod E., Akbari E., Tamtaji O.R., Asemi Z. The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome. Gynecol. Endocrinol. 2017;34:217–222. doi: 10.1080/09513590.2017.1381680.
    1. Izadi A., Shirazi S., Taghizadeh S., Gargari B.P. Independent and Additive Effects of Coenzyme Q10 and Vitamin E on Cardiometabolic Outcomes and Visceral Adiposity in Women with Polycystic Ovary Syndrome. Arch. Med Res. 2019;50:1–10. doi: 10.1016/j.arcmed.2019.04.004.
    1. Verjee L.S., Verhoekx J.S.N., Chan J.K.K., Krausgruber T., Nicolaidou V., Izadi D., Davidson D., Feldmann M., Midwood K.S., Nanchahal J. Unraveling the signaling pathways promoting fibrosis in Dupuytren’s disease reveals TNF as a therapeutic target. Proc. Natl. Acad. Sci. USA. 2013;110:E928–E937. doi: 10.1073/pnas.1301100110.
    1. Lourens W. Could coenzyme Q10 be the treatment for Dupuytren’s disease? BMJ Case Rep. 2019;12:e226419. doi: 10.1136/bcr-2018-226419.
    1. Rowland L.M., Pradhan S., Korenic S., Wijtenburg S., Hong L.E., Edden R.A., Barker P.B. Elevated brain lactate in schizophrenia: A 7 T magnetic resonance spectroscopy study. Transl. Psychiatry. 2016;6:e967. doi: 10.1038/tp.2016.239.
    1. Do K.Q., Cabungcal J.H., Frank A., Steullet P., Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 2009;19:220–230. doi: 10.1016/j.conb.2009.05.001.
    1. Bergman O., Ben-Shachar D. Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia. Can. J. Psychiatry. 2016;61:457–469. doi: 10.1177/0706743716648290.
    1. Imagawa M. Low Erythrocyte Coenzyme Q10Level in Schizophrenic Patients. Psychiatry Clin. Neurosci. 1989;43:143–145. doi: 10.1111/j.1440-1819.1989.tb02562.x.
    1. Maguire Á., Hargreaves A., Gill M. Coenzyme Q10 and neuropsychiatric and neurological disorders: Relevance for schizophrenia. Nutr. Neurosci. 2018;23:756–769. doi: 10.1080/1028415x.2018.1556481.
    1. Kikkawa K., Takehara I., Miyakoshi T., Miyawaki H. Safety of high dose supplementation of coenzyme Q10 in healthy human adults. Jpn. J. Food Chem. Saf. 2007;14:76–81. doi: 10.18891/jjfcs.14.2_76.
    1. Mortensen A.L., Rosenfeldt F., Filipiak K.J. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial. Cardiol. J. 2013;26:147–156. doi: 10.5603/CJ.a2019.0022.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner